Page 34 - SRPSKO DRUŠTVO ISTRAŽIVAČA RAKA

Serbian Association for Cancer Research SDIRSACR

Exosome Isolation and Analysis. Cells. 2019;8(7).

3. Tricarico C, Clancy J, D’Souza-Schorey C. Biology and biogenesis of shed microvesicles. Small GTPases. 2017;8(4):220-
32.

4. Yu L, Zhu G, Zhang Z, Yu Y, Zeng L, Xu Z, et al. Apoptotic bodies: bioactive treasure left behind by the dying cells with
robust diagnostic and therapeutic application potentials. Journal of Nanobiotechnology. 2023;21(1):218.

5. Liu SY, Liao Y, Hosseinifard H, Imani S, Wen QL. Diagnostic Role of Extracellular Vesicles in Cancer: A Comprehensive
Systematic Review and Meta-Analysis. Front Cell Dev Biol. 2021;9:705791.

6. Semeradtova A, Liegertova M, Herma R, Capkova M, Brignole C, Del Zotto G. Extracellular vesicles in cancer´s
communication: messages we can read and how to answer. Molecular Cancer. 2025;24(1):86.
7. Glass SE, Coffey RJ. Recent Advances in the Study of Extracellular Vesicles in Colorectal Cancer. Gastroenterology.
2022;163(5):1188-97.

8. Bastón E, García-Agulló J, Peinado H. The influence of extracellular vesicles on tumor evolution and resistance to
therapy. Physiological Reviews. 2025;105(3):1173-212.

9. Lin Z, Li G, Jiang K, Li Z, Liu T. Cancer therapy resistance mediated by cancer-associated fibroblast-derived extracellular
vesicles: biological mechanisms to clinical significance and implications. Molecular Cancer. 2024;23(1):191.

10. Choudhury AD, Werner L, Ha G, Freeman S, Rhoades J, Reed S, et al. Tumor fraction in circulating free DNA as a
biomarker of disease dynamics in metastatic prostate cancer. Journal of Clinical Oncology. 2018;36(6_suppl):195-.

11. Madanat-Harjuoja LM, Renfro LA, Klega K, Tornwall B, Thorner AR, Nag A, et al. Circulating Tumor DNA as a Biomarker
in Patients With Stage III and IV Wilms Tumor: Analysis From a Children’s Oncology Group Trial, AREN0533. Journal
of Clinical Oncology. 2022;40(26):3047-56.

12. Kumar MA, Baba SK, Sadida HQ, Marzooqi SA, Jerobin J, Altemani FH, et al. Extracellular vesicles as tools and
targets in therapy for diseases. Signal Transduction and Targeted Therapy. 2024;9(1):27.

13. Kalluri R, LeBleu VS. The biology, function and biomedical applications of exosomes. Science.
2020;367(6478):eaau6977.

14. Hoshino A, Costa-Silva B, Shen T-L, Rodrigues G, Hashimoto A, Tesic Mark M, et al. Tumour exosome integrins
determine organotropic metastasis. Nature. 2015;527(7578):329-35.
15. Chen G, Huang AC, Zhang W, Zhang G, Wu M, Xu W, et al. Exosomal PD-L1 contributes to immunosuppression and
is associated with anti-PD-1 response. Nature. 2018;560(7718):382-6.

16. Xavier CPR, Belisario DC, Rebelo R, Assaraf YG, Giovannetti E, Kopecka J, et al. The role of extracellular vesicles in
the transfer of drug resistance competences to cancer cells. Drug Resistance Updates. 2022;62:100833.

17. Sohal IS, Kasinski AL. Emerging diversity in extracellular vesicles and their roles in cancer. Front Oncol.
2023;13:1167717.

18. Tiwari PK, Shanmugam P, Karn V, Gupta S, Mishra R, Rustagi S, et al. Extracellular Vesicular miRNA in Pancreatic
Cancer: From Lab to Therapy. Cancers (Basel). 2024;16(12).

19. Smolarz B, Durczyński A, Romanowicz H, Hogendorf P. The Role of microRNA in Pancreatic Cancer. Biomedicines.
2021;9(10).

20. Chen C, Demirkhanyan L, Gondi CS. The Multifaceted Role of miR-21 in Pancreatic Cancers. Cells. 2024;13(11).

21. Joković SM, Dobrijević Z, Kotarac N, Filipović L, Popović M, Korać A, et al. MiR-375 and miR-21 as Potential Biomarkers
of Prostate Cancer: Comparison of Matching Samples of Plasma and Exosomes. Genes. 2022;13(12):2320.

22. Zeng W, Zhang Y, Wang X, Wang S, Lin T, Su T, et al. Chemical Affinity Capture of Plasma Extracellular Vesicles Enables
Efficient and Large-Scale Proteomic Identification of Prostate Cancer Biomarkers. ACS Nano. 2025;19(16):15896-
911.

19